Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Kanter

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reports|May 1, 1979
Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agentsH S Schwartz, P M Kanter
Molecular Pharmacology|July 1, 1982
A fluorescence enhancement assay for cellular DNA damageP M Kanter, H S Schwartz
Analytical Biochemistry|August 1, 1979
A hydroxylapatite batch assay for quantitation of cellular DNA damageP M Kanter, H S Schwartz
Anti-Cancer Drugs|February 1, 1995
Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigenG M Klaich, P M Kanter
Cancer Research|September 1, 1979
Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivativesP M Kanter, H S Schwartz
The Diabetes Educator|July 1, 1996
Diabetes case management: exploring staff practice patternsP M Kanter, J A Otwell
Anti-Cancer Drugs|June 1, 1994
Induction of dog IL-1 by free and liposomal encapsulated doxorubicinG M Klaich, P M Kanter
Leukemia Research|January 1, 1979
Adriamycin-induced DNA damage in human leukemia cellsP M Kanter, H S Schwartz
Cancer Research|February 1, 1979
Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cellsP M Kanter, H S Schwartz
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|November 1, 1980
Post-repair DNA damage in X-irradiated cultured human tumour cellsP M Kanter, H S Schwartz
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reports|May 1, 1979
Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agentsH S Schwartz, P M Kanter
Molecular Pharmacology|July 1, 1982
A fluorescence enhancement assay for cellular DNA damageP M Kanter, H S Schwartz
Analytical Biochemistry|August 1, 1979
A hydroxylapatite batch assay for quantitation of cellular DNA damageP M Kanter, H S Schwartz
Anti-Cancer Drugs|February 1, 1995
Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigenG M Klaich, P M Kanter
Cancer Research|September 1, 1979
Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivativesP M Kanter, H S Schwartz
The Diabetes Educator|July 1, 1996
Diabetes case management: exploring staff practice patternsP M Kanter, J A Otwell
Anti-Cancer Drugs|June 1, 1994
Induction of dog IL-1 by free and liposomal encapsulated doxorubicinG M Klaich, P M Kanter
Leukemia Research|January 1, 1979
Adriamycin-induced DNA damage in human leukemia cellsP M Kanter, H S Schwartz
Cancer Research|February 1, 1979
Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cellsP M Kanter, H S Schwartz
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|November 1, 1980
Post-repair DNA damage in X-irradiated cultured human tumour cellsP M Kanter, H S Schwartz
Pageof 4